Ozempic, Wegovy, and Rybelsus are part of the glucagon-like peptide-1 receptor agonists (GLP-1 RA) drug class, all containing the same primary active component, semaglutide
[70] Coverage for people with obesity and at least one comorbidity (elevated LDL-cholesterol, high blood pressure and/or MASLD) may be implemented as early as April 2026
Risk: Bone and Muscle Loss Rapid weight loss with GLP1 medications affects more than just body fat
doi:10.1177/15598276231167778 Bellicha A, van Baak MA, Battista F, et al
Signs of dehydration include decreased urine output, dark urine, dizziness, and dry mouth
Act quickly if you feel severe abdominal pain, notice changes in your vision, or see signs of acute pancreatitis